Life Technologies to Distribute Quidel MDx Assays | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies will distribute and sell Quidel's molecular diagnostic assays in Europe under an agreement announced today.

Beginning next month, Life Tech will begin selling two Quidel molecular diagnostic tests — the Influenza A+B Real-Time RT-PCR Assay and the human metapneumovirus (hMPV) assays. Quidel had announced yesterday that its hMPV test had received the CE Mark. Its influzenza test received the CE Mark in August.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.